Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending February 09, 2007. The report serves as a notification of transactions involving Directors, Persons Discharging Managerial Responsibility, or Connected Persons in the company's Ordinary Shares, filed pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a regulatory notification regarding share transactions and does not contain financial performance data.
Material Changes
The filing details specific share transfers from the GlaxoSmithKline Employee Trust ("the GSK Trust") to participants in the SmithKline Beecham Employee Share Option Plan 1991:
- February 6, 2007: Transfer of 23,178 Ordinary Shares.
- February 7, 2007: Transfer of 25,422 Ordinary Shares.
These transactions were advised to the Company on February 8, 2007. The GSK Trust is a discretionary trust where all employees or former employees are potential beneficiaries. Three directors (Dr J-P Garnier, Dr M M Slaoui, and Mr J S Heslop) hold interests in the shares held by the trust in the same capacity as other employees.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is strictly a disclosure of director and connected person share transactions.
Investor Verification Points
- Verify the total number of shares transferred to the SmithKline Beecham Employee Share Option Plan 1991 (48,600 shares total across two dates).
- Confirm the status of the GSK Trust as a discretionary trust for current and former employees.
- Note that the filing does not impact the company's financial statements directly but discloses changes in beneficial ownership interests.